Summary & Overview
HCPCS Level II V5181: Hearing Aid, Contralateral Routing Device, Monaural
HCPCS Level II code V5181 denotes a monaural, behind-the-ear (BTE) contralateral routing hearing aid used to route sound from one ear to the other for patients with unilateral hearing loss. This code identifies a specific durable medical equipment device commonly furnished by audiology providers, ENT clinics, and hearing aid dispensaries. Nationally, accurate coding for assistive hearing devices matters for access to proper prosthetic services, standardized reimbursement, and claims consistency across commercial and public payers.
Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the device and service context, typical sites of service, and payers commonly involved in coverage decisions. The publication also summarizes benchmarking and policy considerations relevant to device coding, coverage determinations, and documentation expectations for durable medical equipment claims. The content is designed to help billing managers, audiology program leads, and policy analysts understand how HCPCS Level II code V5181 is used in clinical and administrative workflows, what to expect from major payers, and where to look for further guidance.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Billing Code Overview
HCPCS Level II code V5181 represents a hearing aid, contralateral routing device, monaural, behind the ear (BTE). This device is intended to route sound from one ear to the other for patients with unilateral hearing loss, providing an asymmetric amplification solution.
Service Type: Durable medical equipment — hearing aid/assistive listening device
Typical Site of Service: Outpatient audiology clinic, audiologist office, hearing aid dispensary, or outpatient ENT clinic
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with unilateral severe-to-profound sensorineural hearing loss who retains usable hearing in the better ear and is fitted with a contralateral routing of signal (CROS) hearing system. The device described by V5181 is a monaural, behind-the-ear (BTE) contralateral routing device used when amplification in the poorer ear provides no functional benefit and sounds from the poorer ear must be routed to the better ear. Clinical workflow begins with an otologic and audiologic evaluation in an outpatient ENT or audiology clinic: medical history, otoscopic exam, and pure-tone and speech audiometry including unaided and aided testing and real-ear measures as appropriate. Counseling about CROS candidacy is provided. After candidacy is confirmed, device selection, earmold impressions or BTE coupling checks, device ordering and payer preauthorization occur. Device delivery appointment includes fitting, programming, verification (real-ear or simulated measures), and patient education on insertion, care, and realistic expectations. Follow-up visits address comfort, device adjustments, and outcome measures (speech-in-noise testing, self-reported benefit). Typical site of service is an outpatient audiology clinic or ENT clinic; durable medical equipment suppliers may also perform delivery and ongoing device support. Typical modifiers used in billing may reflect laterality (LT/RT), payer-specific supply or rental status (GY), and unusual procedural complexity (22).
Coding Specifications
| Modifier |
|---|